Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ascendis Pharma A/S (ASND)

91.09   -0.38 (-0.42%) 06-26 23:20
Open: 92.67 Pre. Close: 91.47
High: 93.89 Low: 86.23
Volume: 785,095 Market Cap: 5,083(M)
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 93.94 - 94.42 94.42 - 94.79
Low: 85.18 - 85.65 85.65 - 86.02
Close: 90.31 - 91.14 91.14 - 91.77

Technical analysis

as of: 2022-06-24 4:38:07 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 114.59     One year: 133.84
Support: Support1: 85.23    Support2: 77.27
Resistance: Resistance1: 98.11    Resistance2: 114.59
Pivot: 85.3
Moving Average: MA(5): 87.54     MA(20): 85.36
MA(100): 101.93     MA(250): 124.45
MACD: MACD(12,26): -0.8     Signal(9): -2
Stochastic oscillator: %K(14,3): 78.2     %D(3): 67.2
RSI: RSI(14): 55.7
52-week: High: 178.71  Low: 61.57
Average Vol(K): 3-Month: 521 (K)  10-Days: 362 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ASND ] has closed below upper band by 12.9%. Bollinger Bands are 22.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
Ascendis Pharma A/S (NASDAQ:ASND) Stock Price Down 2% - Defense World

Tue, 14 Jun 2022
Ascendant Resources Announces Discovery of New Copper-Gold Zone and Reports Additional Strong Results From Its Infill Campaign at Lagoa Salgada, Portugal - Junior Mining Network

Fri, 10 Jun 2022
Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money - Simply Wall St

Wed, 25 May 2022
Ascendant Resources Acquires 50% Ownership of Lagoa Salgada VMS Project, Portugal -

Mon, 23 May 2022
Should Biotechnology Stock Ascendis Pharma A/S (ASND) Be in Your Portfolio Monday? - InvestorsObserver

Thu, 12 May 2022
Why Ascendis Pharma Stock Is Sinking Today - The Motley Fool

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 57 (M)
% Held by Insiders 4.417e+007 (%)
% Held by Institutions 0 (%)
Shares Short 6,320 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -4.4781e+008
EPS Est Next Qtl 0.01
EPS Est This Year -0.15
EPS Est Next Year 0.14
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -5
Return on Assets (ttm) 808.5
Return on Equity (ttm) -27.4
Qtrly Rev. Growth 7.78e+006
Gross Profit (p.s.) 1132.36
Sales Per Share -61.87
EBITDA (p.s.) 5.90278e+006
Qtrly Earnings Growth -8.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -418 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 7.7
Price to Book value 0
Price to Sales -1.48
Price to Cash Flow 3.75

Stock Dividends

Dividend 0
Forward Dividend 5.76e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.